Mouse Anti Human Factor IX Heavy Chain

<strong>Mouse Anti Human Factor IX Heavy Chain </strong>_x000D_ <strong>Catalog number:</strong> B2017884_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -80°C_x000D_ <strong>Keywords:</strong> Anti human Factor IX monoclonal_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Matafonov A, Cheng Q, Geng Y, Verhamme IM, Umunakwe O, Tucker EI, Sun MF, Serebrov V, Gruber A, Gailani D. Evidence for factor IX-independent roles for factor XIa in blood coagulation J Thromb Haemost. 2013 Dec;11(12):2118-27._x000D_ 2: Bradford HN, Dela Cadena RA, Kunapuli SP, Dong JF, Löpez JA, Colman RW. Human kininogens regulate thrombin binding to platelets through the glycoprotein Ib-IX-V complex Blood. 1997 Aug 15;90(4):1508-15._x000D_ 3: Yang J, Ji S, Dong N, Zhao Y, Ruan C. Engineering and characterization of a chimeric anti-platelet glycoprotein Ibalpha monoclonal antibody and preparation of its Fab fragment Hybridoma (Larchmt). 2010 Apr;29(2):125-32._x000D_ 4: Kinderlerer AR, Pombo Gregoire I, Hamdulay SS, Ali F, Steinberg R, Silva G, Ali N, Wang B, Haskard DO, Soares MP, Mason JC. Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin Blood. 2009 Feb 12;113(7):1598-607._x000D_ 5: Shan L. (125)I-Labeled mouse anti-human carbonic anhydrase IX monoclonal antibody 2012 May 3 [updated 2012 May 30]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013._x000D_ 6: Østergaard H, Lund J, Greisen PJ, Kjellev S, Henriksen A, Lorenzen N, Johansson E, Røder G, Rasch MG, Johnsen LB, Egebjerg T, Lund S, Rahbek-Nielsen H, Gandhi PS, Lamberth K, Loftager M, Andersen LM, Bonde AC, Stavenuiter F, Madsen DE, Li X, Holm TL, Ley CD, Thygesen P, Zhu H, Zhou R, Thorn K, Yang Z, Hermit MB, Bjelke JR, Hansen BG, Hilden I. A factor VIIIa-mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice Blood. 2021 Oct 7;138(14):1258-1268._x000D_ 7: Chang DK, Moniz RJ, Xu Z, Sun J, Signoretti S, Zhu Q, Marasco WA. Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo Mol Cancer. 2015 Jun 11;14:119._x000D_ 8: Wu Q, Parry G. Hepsin and prostate cancer Front Biosci. 2007 Sep 1;12:5052-9._x000D_ 9: Persson KE, Knobe KE, Stenflo J. An anti-EGF monoclonal antibody that detects intramolecular communication in factor IX Biochem Biophys Res Commun. 2001 Sep 7;286(5):1039-44._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/3873655">10: Wallmark A, Ljung R, Nilsson IM, Holmberg L, Hedner U, Lindvall M, Sjögren HO. Polymorphism of normal factor IX detected by mouse monoclonal antibodies Proc Natl Acad Sci U S A. 1985 Jun;82(11):3839-43. </a>_x000D_ _x000D_ <strong>Products Related to Mouse Anti Human Factor IX Heavy Chain can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>